Treatment Outcomes of Immune-Related Cutaneous Adverse Events.
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333
Informations de publication
Date de publication:
20 10 2019
20 10 2019
Historique:
pubmed:
20
6
2019
medline:
11
6
2020
entrez:
20
6
2019
Statut:
ppublish
Résumé
The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to checkpoint inhibitors in an uncontrolled cohort of patients referred to oncodermatology clinics. A retrospective analysis of patients with ircAEs evaluated by dermatologists from January 1, 2014, to December 31, 2017, at three tertiary care hospitals and cancer centers were identified through electronic medical records. Clinicopathologic characteristics, dermatologic therapy outcome, and laboratory data were analyzed. A total of 285 patients (median age, 65 years [range, 17 to 89 years]) with 427 ircAEs were included: pruritus (n = 138; 32%), maculopapular rash (n = 120; 28%), psoriasiform rash (n = 22; 5%), and others (n = 147; 34%). Immune checkpoint inhibitor class was associated with ircAE phenotype ( Most ircAEs responded to symptom- and phenotype-directed dermatologic therapies, whereas biologic therapies were effective in patients with corticosteroid-refractory disease. Increased eosinophils, IL-6, IL-10, and immunoglobulin E were associated with ircAEs, and they may represent actionable therapeutic targets for immune-related skin toxicities.
Identifiants
pubmed: 31216228
doi: 10.1200/JCO.18.02141
pmc: PMC7001790
doi:
Substances chimiques
Immunologic Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2746-2758Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Références
Eur J Cancer. 2016 Jun;60:12-25
pubmed: 27043866
Lung Cancer. 2017 Jul;109:42-44
pubmed: 28577948
Cancer Treat Rev. 2016 Mar;44:51-60
pubmed: 26874776
Eur J Cancer. 2016 Feb;54:139-148
pubmed: 26765102
J Am Acad Dermatol. 2019 Apr;80(4):990-997
pubmed: 30399387
Front Pharmacol. 2017 Feb 08;8:49
pubmed: 28228726
Mayo Clin Proc. 2017 Jul;92(7):1158-1163
pubmed: 28599746
Blood. 2016 Jun 30;127(26):3321-30
pubmed: 27207799
JAMA Dermatol. 2019 Feb 1;155(2):249-251
pubmed: 30540342
JAMA Oncol. 2016 Oct 1;2(10):1346-1353
pubmed: 27367787
Clin Cancer Res. 2016 Sep 15;22(18):4550-5
pubmed: 27435397
J Clin Oncol. 2017 Dec 1;35(34):3815-3822
pubmed: 28915085
JAMA Dermatol. 2015 Nov;151(11):1206-1212
pubmed: 26222619
Am J Surg Pathol. 2017 Oct;41(10):1381-1389
pubmed: 28817405
Cancer Immunol Res. 2016 May;4(5):383-9
pubmed: 26928461
Lancet Oncol. 2012 Oct;13(10):1020-4
pubmed: 22995650
Cancer J. 2014 Mar-Apr;20(2):119-22
pubmed: 24667956
Eur J Dermatol. 2016 Oct 1;26(5):427-443
pubmed: 27550571
Chin Med Sci J. 2018 Sep 20;33(3):183-187
pubmed: 30266109
JAAD Case Rep. 2017 Mar 02;3(2):90-92
pubmed: 28280766
Nat Rev Clin Oncol. 2016 Aug;13(8):473-86
pubmed: 27141885
Clin Cancer Res. 2016 Aug 15;22(16):4023-9
pubmed: 26957557
J Thorac Dis. 2018 Jun;10(6):E481-E484
pubmed: 30069410
Curr Probl Cancer. 2017 Mar - Apr;41(2):125-128
pubmed: 28190531
J Cutan Pathol. 2017 Feb;44(2):158-176
pubmed: 27859479
Cancer Res. 2017 Mar 15;77(6):1322-1330
pubmed: 28031229
J Clin Oncol. 2017 Mar;35(7):785-792
pubmed: 28068177
JAMA Dermatol. 2016 Oct 1;152(10):1128-1136
pubmed: 27411054
Br J Dermatol. 2017 Jun;176(6):1649-1652
pubmed: 27943234
J Clin Oncol. 2018 Oct 1;36(28):2872-2878
pubmed: 30125216
J Am Acad Dermatol. 2017 May;76(5):863-870
pubmed: 28094061
Ann Rheum Dis. 2017 Dec;76(12):2061-2064
pubmed: 28830882
Oncologist. 2017 Oct;22(10):1232-1237
pubmed: 28652280
J Am Acad Dermatol. 2018 Dec;79(6):1047-1052
pubmed: 29857011
Cancer. 2013 May 1;119(9):1675-82
pubmed: 23400564
Cancer Treat Rev. 2016 Apr;45:7-18
pubmed: 26922661
J Hematol Oncol. 2016 Sep 05;9(1):81
pubmed: 27595932
Cancer. 2018 Sep 15;124(18):3706-3714
pubmed: 29975414
Immunotherapy. 2016 Dec;8(12):1437-1446
pubmed: 28000535
JAMA Oncol. 2018 Dec 1;4(12):1721-1728
pubmed: 30242316
Lancet Oncol. 2017 Dec;18(12):1600-1609
pubmed: 29129441
Am J Clin Dermatol. 2018 Jun;19(3):345-361
pubmed: 29256113
J Am Acad Dermatol. 2013 Sep;69(3):e121-8
pubmed: 23357570
Medicine (Baltimore). 2018 Dec;97(52):e13810
pubmed: 30593172
Clin Cancer Res. 2016 Feb 15;22(4):886-94
pubmed: 26446948
Ann Oncol. 2015 Dec;26(12):2375-91
pubmed: 26371282
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
Pediatr Blood Cancer. 2017 Dec;64(12):
pubmed: 28544595
J Am Acad Dermatol. 2018 Dec;79(6):1081-1088
pubmed: 30025829
Clin Lung Cancer. 2019 May;20(3):201-207
pubmed: 30442524
Ann Oncol. 2016 Apr;27(4):559-74
pubmed: 26715621
Hemodial Int. 2017 Jan;21(1):63-71
pubmed: 27397522
Cell. 2017 Sep 21;171(1):217-228.e13
pubmed: 28890086
J Clin Oncol. 2015 Mar 1;33(7):773-81
pubmed: 25605840
Oncoimmunology. 2016 Sep 19;5(11):e1231292
pubmed: 27999741
Acta Oncol. 2018 May;57(5):705-708
pubmed: 29171332
N Engl J Med. 2013 Mar 7;368(10):924-35
pubmed: 23432142
J Immunol Methods. 2016 Jul;434:1-8
pubmed: 27049586
J Immunother. 2016 Apr;39(3):149-52
pubmed: 26938948
Pigment Cell Melanoma Res. 2017 Jan;30(6):511-520
pubmed: 28950054
Curr Opin Oncol. 2016 Jul;28(4):254-63
pubmed: 27136138
J Clin Oncol. 2012 Jul 20;30(21):2691-7
pubmed: 22614989
JAMA Dermatol. 2017 Jun 1;153(6):603-605
pubmed: 28355425
JAMA Oncol. 2018 Jan 1;4(1):98-101
pubmed: 28817755
JAMA Oncol. 2018 Aug 1;4(8):1118-1119
pubmed: 29801033
Clin Cancer Res. 2019 Mar 1;25(5):1557-1563
pubmed: 30409824
Clin Exp Dermatol. 2019 Aug;44(6):643-646
pubmed: 30618056
Ann Oncol. 2017 Oct 1;28(10):2377-2385
pubmed: 28945858
Acta Derm Venereol. 2014 Jan;94(1):38-44
pubmed: 23722308
Clin Exp Dermatol. 2018 Jul;43(5):598-599
pubmed: 29333653
Case Rep Oncol. 2018 Sep 7;11(3):615-621
pubmed: 30323751
J Eur Acad Dermatol Venereol. 2017 May;31(5):e254-e257
pubmed: 27739129
Cancer Immunol Res. 2018 Sep;6(9):1093-1099
pubmed: 29991499
Cancer Res. 2016 Sep 15;76(18):5288-301
pubmed: 27503925
Ann Oncol. 2016 Jul;27(7):1199-206
pubmed: 27122549
JAAD Case Rep. 2018 Nov 10;4(10):1042-1044
pubmed: 30456282
Am J Dermatopathol. 2017 Feb;39(2):121-129
pubmed: 28134729
Transl Lung Cancer Res. 2015 Oct;4(5):560-75
pubmed: 26629425
Respir Med Case Rep. 2017 Oct 26;22:283-286
pubmed: 29124007